Brief: Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million
06/08/2026 12:01
BRIEF-Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million Aug 06 (Reuters) - Cartesian Therapeutics Inc Q2 operating income USD -29.155 million.
- Q2 operating expenses USD 29.155 million
Recent news on Cartesian Therapeutics
See all newsBrief: Cartesian Therapeutics Announces Additional Retreatment Data For Descartes-08 Highlighting Deep And Durable Responses In Patients With Myasthenia Gravis
Cartesian Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cartesian Therapeutics Q2 net income steady
Brief: Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million
Cartesian Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview